# JAMA Dermatology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/jama-dermatology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 114,482 |
| h-index | 134 |
| Homepage | http://archderm.ama-assn.org/ |
| Open Access | false |
| ISSN-L | 2168-6068 |
| ISSNs | 2168-6068,2168-6084 |
| OpenAlex ID | https://openalex.org/S146641495 |
| Publisher | American Medical Association |
| Works | 5,004 |

## Journal papers

Showing 12 of 38.

- [Global Skin Disease Morbidity and Mortality](https://scholariq.org/papers/global-skin-disease-morbidity-and-mortality/)
- [Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adolescents-with-uncontrolled-moderate-to/)
- [Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/)
- [Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-patients-with-moderate-to-severe-atopic/)
- [Long-term Management of Adult Vulvar Lichen Sclerosus](https://scholariq.org/papers/long-term-management-of-adult-vulvar-lichen-sclerosus/)
- [Psoriasis and the Risk of Diabetes Mellitus](https://scholariq.org/papers/psoriasis-and-the-risk-of-diabetes-mellitus/)
- [Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks](https://scholariq.org/papers/expert-level-diagnosis-of-nonpigmented-skin-cancer-by-combined-convolutional/)
- [Comparison of Biologics and Oral Treatments for Plaque Psoriasis](https://scholariq.org/papers/comparison-of-biologics-and-oral-treatments-for-plaque-psoriasis/)
- [Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa](https://scholariq.org/papers/safety-and-efficacy-of-anakinra-in-severe-hidradenitis-suppurativa/)
- [Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-multiple-dupilumab-dose-regimens-after-initial-successful/)
- [Frequency of Debridements and Time to Heal](https://scholariq.org/papers/frequency-of-debridements-and-time-to-heal/)
- [Adverse Events Associated With Mohs Micrographic Surgery](https://scholariq.org/papers/adverse-events-associated-with-mohs-micrographic-surgery/)

## Journal top topics

Showing 8 of 24.

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.